Biotech and Healthcare investors in Asia-Pacific

    18 funds · Updated

    Gatsbie lists 18 Biotech and Healthcare investors headquartered in Asia-Pacific (as of 2026-11-18).

    Each one names both biotech & life sciences and healthcare & medtech in its investment focus.

    Most are based in India (5), China (4) and Singapore (3); the most common stages are Seed (14), Series A (14) and Series B (10); the most common kinds of capital are Venture equity (16), Growth equity (4) and Debt (2).

    Which Biotech and Healthcare investors are based in Asia-Pacific?

    Gatsbie lists 18 Biotech and Healthcare investors headquartered in Asia-Pacific (as of 2026-11-18). Most are in India (5), China (4) and Singapore (3). They include Pix Vine Capital (Singapore), Ankur Capital (Mumbai), GRC SinoGreen Fund (Cayman Islands), IMM Investment, Corp. (Seoul), NIIF | India's premier sovereign-anchored alternative assets manager (Mumbai) and Verge Healthtech Fund (Singapore).

    Which family offices invest in Biotech and Healthcare in Asia-Pacific?

    3 of the 18 Biotech and Healthcare investors on Gatsbie are family offices, including CYRUS POONAWALLA GROUP (FAMILY OFFICE), ERAGON FAMILY OFFICE and JMCR Partners.

    Upload your deck to see which of these fit your startup, with a written reason for each.

    18 funds

    Most active first: deals in the last 24 months, then portfolio companies on record.

    #FundHQStagesPartner emails
    1Pix Vine CapitalSingaporePre-Seed–Series B 2
    2Ankur CapitalMumbaiPre-Seed–Series A 12
    3GRC SinoGreen FundCayman IslandsSeries C+ 11
    4IMM Investment, Corp.SeoulSeed–Series C+ 10
    5NIIF | India's premier sovereign-anchored alternative assets managerMumbaiGrowth 6
    6Verge Healthtech FundSingaporePre-Seed–Series A 9
    7Unicorn India VenturesMumbaiSeed, Series A 1
    8CYRUS POONAWALLA GROUP (FAMILY OFFICE)PuneSeries C+, Growth 3
    9ERAGON FAMILY OFFICEMumbaiSeed–Series B, Growth 1
    10Ally Bridge GroupHong KongSeed–Series C+ 14
    11LYFE CapitalShanghaiSeed–Series B, Growth 4
    12Ecliptic Venture CapitalAucklandPre-Seed–Series B 3
    13JMCR PartnersHong KongSeed, Series C+ 2
    14DigiTx PartnersBrisbanePre-Seed–Series A 3
    15Newgen Venture PartnersShanghaiPre-Seed–Series B 4
    16Ion PacificHong KongSeed–Series B 17
    17Main SequenceSydneyPre-Seed–Series B 15
    18The Hina GroupSan FranciscoSeries A, Series B, Growth, Mature 9

    Other sector pairs

    Biotech and Healthcare investors elsewhere

    Counted by where each fund is headquartered, from public sources, as of 2026-11-18. Only funds naming both sectors are listed.

    How to pick an investor search tool